Our data suggested that only LCL-PLP reduced the expression of CD31 in tumor tissue (Figure 7A) suggesting that only this treatment might affect significantly the involvement of endothelial cells in tumor angiogenesis. The gene discussed is PECAM1; the disease is neoplasm.